titanium has been researched along with Neointima in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Antaki, JF; Butcher, JT; He, W; Rowlands, GW | 1 |
| Hattori, H; Ichihara, Y; Kikuchi, N; Niinami, H; Nunoda, S; Saito, S; Yamada, Y; Yoshizawa, S | 1 |
| Aguilera, MC; Alfonso, F; Antuña, P; Diego, G; Rivero, F; Rodríguez, D | 1 |
| Fan, Y; Li, W; Liu, J; Weng, Y; Xie, Y; Zeng, Z; Zhang, Y | 1 |
| Annala, AP; Karjalainen, PP; Kiviniemi, TO; Lehtinen, T; Nammas, W; Ylitalo, A | 1 |
| Airaksinen, JK; Biancari, F; Karjalainen, P; Kiviniemi, TO; Lehtinen, T; Mikkelsson, J; Nammas, W; Pietila, M; Saraste, A; Ylitalo, A | 1 |
| Ahn, Y; Bae, IH; Cho, DL; Hong, YJ; Jeong, HY; Jeong, MH; Kim, HS; Kim, JH; Kim, JM; Kim, YS; Lim, KS; Park, DS; Park, JK; Park, KH; Sim, DS; Song, SJ; Yang, EJ | 1 |
| Airaksinen, JK; Karjalainen, PP; Kiviniemi, TO; Mikkelsson, J; Nammas, W; Perälä, A; Pietilä, M; Romppanen, H; Sia, J; Tuomainen, P; Varho, V | 1 |
| Karjalainen, PP; Nammas, W | 1 |
| Airaksinen, JK; Karjalainen, PP; Kiviniemi, TO; Nammas, W; Pietilä, M; Romppanen, H; Sia, J; Varho, V | 1 |
| Karjalainen, P; Nammas, W; Paana, T; Sia, J; Ylitalo, A | 1 |
| Chorna, N; Haworth, P; Lazarenko, O; Mikhalovska, L; Mikhalovsky, S; Sudre, A | 1 |
| Mizuno, T; Nishinaka, T; Taenaka, Y; Tatsumi, E; Yamada, Y; Yamazaki, K | 1 |
| Airaksinen, KE; Karjalainen, PP; Lehtinen, T; Ylitalo, A | 1 |
2 review(s) available for titanium and Neointima
| Article | Year |
|---|---|
Biological Response to Sintered Titanium in Left Ventricular Assist Devices: Pseudoneointima, Neointima, and Pannus.
Topics: Animals; Biological Products; Heart-Assist Devices; Neointima; Pannus; Thrombosis; Titanium | 2023 |
Titanium-nitride-oxide-coated coronary stents: insights from the available evidence.
Topics: Acute Coronary Syndrome; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Angiography; Female; Humans; Male; Neointima; Observational Studies as Topic; Stents; Titanium; Treatment Outcome | 2017 |
5 trial(s) available for titanium and Neointima
| Article | Year |
|---|---|
Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.
Topics: Acute Coronary Syndrome; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Circulation; Coronary Vessels; Drug-Eluting Stents; Echocardiography, Doppler, Color; Echocardiography, Doppler, Pulsed; Everolimus; Humans; Hyperplasia; Neointima; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Single-Blind Method; Sirolimus; Stents; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome; Vasodilation | 2013 |
Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Chromium; Coated Materials, Biocompatible; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Finland; Fractional Flow Reserve, Myocardial; Humans; Hyperplasia; Male; Microcirculation; Middle Aged; Neointima; Nitric Oxide; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Single-Blind Method; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome; Vascular Resistance; Vasodilator Agents; Wound Healing | 2016 |
Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Observer Variation; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Statistics, Nonparametric; Time Factors; Titanium; Tomography, Optical Coherence; Wound Healing | 2017 |
Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Coated Materials, Biocompatible; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Neointima; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2017 |
Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Stents; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2012 |
7 other study(ies) available for titanium and Neointima
| Article | Year |
|---|---|
Clinical Validation of a Neointima-Inducing Inflow Cannula in a Continuous Flow Left Ventricular Assist Device.
Topics: Cannula; Heart-Assist Devices; Humans; Neointima; Retrospective Studies; Thromboembolism; Thrombosis; Titanium | 2023 |
Very Late Stent Thrombosis of a Titanium-Nitride-Oxide-Coated Bioactive Stent Resulting From Neoatherosclerosis: Optical Coherence Tomography Insights.
Topics: Coronary Restenosis; Humans; Neointima; Percutaneous Coronary Intervention; Stents; Thrombosis; Titanium; Tomography, Optical Coherence | 2020 |
Selective endothelialization and alleviation of neointimal hyperplasia by functionalizing the Ti-O surface with l-selenocystine and KREDVC.
Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cell Proliferation; Coculture Techniques; Cystine; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Hyperplasia; Indoles; Macrophages; Male; Myocytes, Smooth Muscle; Neointima; Nitric Oxide; Oligopeptides; Organoselenium Compounds; Polymers; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Stereoisomerism; Titanium; von Willebrand Factor | 2019 |
Vascular healing early after titanium-nitride-oxide-coated stent implantation assessed by optical coherence tomography.
Topics: Aged; Cohort Studies; Coronary Artery Disease; Endothelium, Vascular; Equipment Failure; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Prevalence; Prospective Studies; Registries; Stents; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2013 |
Effect of polymer-free TiO2 stent coated with abciximab or alpha lipoic acid in porcine coronary restenosis model.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Fibrin; Hyperplasia; Immunoglobulin Fab Fragments; Inflammation; Male; Neointima; Percutaneous Coronary Intervention; Polymers; Swine; Thioctic Acid; Time Factors; Titanium; Treatment Outcome | 2014 |
Inorganic coatings for cardiovascular stents: In vitro and in vivo studies.
Topics: Animals; Aorta; Carbon; Cell Proliferation; Coated Materials, Biocompatible; Endothelial Cells; Fibrinogen; Humans; Materials Testing; Neointima; Platelet Adhesiveness; Stainless Steel; Stents; Titanium; Zirconium | 2011 |
Neointima-inducing inflow cannula with titanium mesh for left ventricular assist device.
Topics: Animals; Catheters; Cattle; Heart-Assist Devices; Immunohistochemistry; Neointima; Thrombosis; Tissue Scaffolds; Titanium | 2011 |